LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹131 Cr | ₹117 Cr | ₹96 Cr | ₹111 Cr | ₹95 Cr |
What is the latest Total Current Liabilities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹131 Cr |
| Mar2024 | ₹117 Cr |
| Mar2023 | ₹96 Cr |
| Mar2022 | ₹111 Cr |
| Mar2021 | ₹95 Cr |
How is Total Current Liabilities of LINCOLN PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹131 Cr | 11.65 | |
| Mar2024 | ₹117 Cr | 22.29 | |
| Mar2023 | ₹96 Cr | -13.27 | |
| Mar2022 | ₹111 Cr | 16.80 | |
| Mar2021 | ₹95 Cr | - | |
Compare Total Current Liabilities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,225.7 Cr | 2.3% | 2.6% | 11.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 2.3% |
2.6% |
11.1% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses